Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Turning Clinical Results Into Change for Patients with Prostate Cancer

In a recent interview with CURE®’s sister publication, Cancer Network®, Dr. Michael J. Morris discussed the results of the phase 3 CONDOR trial, presented during the 2020 ASCO Virtual Scientific Program, and how they will eventually impact patients by changing the way prostate cancer is identified and evaluated. The trial investigated the use of positron emission tomography, or PET, scans specifically targeted to locate accumulations of a protein called prostate-specific membrane antigen (PSMA), indicating that prostate cancer is present.

Watch here.

source: Dr. Michael Morris - CURE Today